FDA Inspection
CSL Behring GmbHCSL Behring GmbH – FDA Inspection, Feb 18, 2026
Record Details
This FDA Inspection record concerns CSL Behring GmbH, with an inspection on February 18, 2026, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 6f5be157-f53f-42b2-97ad-463453dd2735
Inspection Facts
- Inspection number
- 1298394
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
5- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 600.14(a)(1)Who must report - manufacturer
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Behring GmbH
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2024 | Not classified | Office of Inspections and Investigations | |
| April 18, 2024 | Not classified | Office of Inspections and Investigations | Compliance: Devices |
| March 4, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 17, 2018 | Not classified | Office of Inspections and Investigations | |
| May 17, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring GmbH
- FDA Inspection 1242677 - 2024-04-30
- FDA Inspection 1231683 - 2024-04-18
- FDA Inspection 1166653 - 2022-03-04
- FDA Inspection 1052244 - 2018-05-17
- FDA Inspection 1007037 - 2016-05-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.